- #442534
- 190
- Genentech USA #50242004164
Cathflo® Activase® Alteplase 2 mg Injection Single-Use Vial 2 mg
CATHFLO, ACTIVASE 2MG VL
Features
- Produced by recombinant DNA technology, Cathflo* is a fibrin-specific t-PA
- Cathflo* is indicated for the restoration of function to central venous access devices (CVADs), as assessed by the ability to withdraw blood
- More …
Product Details Email
Product Specifications
McKesson # | 442534 |
Manufacturer # | 50242004164 |
Brand | Cathflo® Activase® |
Manufacturer | Genentech USA |
Country of Origin | United States |
Alternate Manufacturer Number | 1642750 |
Application | Thrombolytic Agent |
Container Type | Single-Use Vial |
Dosage Form | Injection |
Generic Drug Code | 13922 |
Generic Drug Name | Alteplase |
NDC Number | 50242004164 |
Product Dating | McKesson Acceptable Dating: we will ship >= 180 days |
Storage Requirements | Requires Refrigeration |
Strength | 2 mg |
UNSPSC Code | 51412702 |
Volume | 2 mg |
Features
- Produced by recombinant DNA technology, Cathflo* is a fibrin-specific t-PA
- Cathflo* is indicated for the restoration of function to central venous access devices (CVADs), as assessed by the ability to withdraw blood
More Information
Professionals Also Viewed
- #904182
- 22
- Genentech USA #50242008527
- Activase is a tissue plasminogen activator (tPA) indicated for the tre …
- 活化酶被证明是减少患者的残疾s treated within 3 h …
- Each 100 mg Activase vial (58 million IU) is packaged with diluent for …
No Image
- #1168934
- 12
- Genentech USA #50242012047
- #904177
- Genentech USA #50242004413
- Activase® (alteplase) is indicated for the treatment of acute ischemic …
- Activase® is indicated for use in acute myocardial infarction (AMI) fo …
- Activase® is indicated for the lysis of acute massive pulmonary emboli …